1. Govaere, Olivier, Cockell, Simon, Tiniakos, Dina, Daly, Ann K, Anstee, Quentin M. . Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. In Science translational medicine, 12, . doi:10.1126/scitranslmed.aba4448. https://pubmed.ncbi.nlm.nih.gov/33268509/
2. Qu, Jiayao, Li, Jia, Zhang, Yaming, Xia, Chenglai, Luo, Dixian. 2021. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway. In Cell & bioscience, 11, 163. doi:10.1186/s13578-021-00677-3. https://pubmed.ncbi.nlm.nih.gov/34419144/
3. Li, Jia, Guo, Yuanwei, Duan, Lili, Zhu, Yuan-Shan, Luo, Di-Xian. . AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling. In Oncotarget, 8, 33694-33703. doi:10.18632/oncotarget.16624. https://pubmed.ncbi.nlm.nih.gov/28402270/
4. Wang, Huiwen, Zhang, Jian, Liu, Jinqing, Fu, Lei, Peng, Shifang. 2023. Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation. In Frontiers in molecular biosciences, 10, 1124956. doi:10.3389/fmolb.2023.1124956. https://pubmed.ncbi.nlm.nih.gov/36845547/
5. Endo, Satoshi, Matsunaga, Toshiyuki, Nishinaka, Toru. 2021. The Role of AKR1B10 in Physiology and Pathophysiology. In Metabolites, 11, . doi:10.3390/metabo11060332. https://pubmed.ncbi.nlm.nih.gov/34063865/
6. Govaere, Olivier, Hasoon, Megan, Alexander, Leigh, Daly, Ann K, Anstee, Quentin M. 2023. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. In Nature metabolism, 5, 572-578. doi:10.1038/s42255-023-00775-1. https://pubmed.ncbi.nlm.nih.gov/37037945/
7. Yang, Sa, Cao, Shi-Jie, Li, Cong-Yu, Qiu, Feng, Kang, Ning. 2024. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD. In Journal of ethnopharmacology, 332, 118354. doi:10.1016/j.jep.2024.118354. https://pubmed.ncbi.nlm.nih.gov/38762210/